首页> 外国专利> Direct conversion method of mesenchymal stromal stem cells to endothelial cells by defined transcription factors

Direct conversion method of mesenchymal stromal stem cells to endothelial cells by defined transcription factors

机译:明确转录因子将间充质干细胞直接转化为内皮细胞的方法

摘要

The present invention relates to a method for converting mesenchymal stem cells into endothelial cells by using specific transcription factors. More specifically, the present invention relates to a method for converting mesenchymal stem cells into endothelial cells by using specific transcription factors such as Oct4, Nanog, Tal1 and LMO2. According to the present invention, two kinds of genes that are not directly related to cancer induction among the reprogramming factors of the cell and the other two types of transcription factors that are not expressed in mesenchymal stem cells or are expressed at low levels among the transcription factors related to vascular development are selected and combined such that a method for converting mesenchymal stem cells such as adult cells or adult stem cells into endothelial cells is developed, and thus, the method has an effect of being applied to the production of endothelial cells to constitute regenerative tissue in tissue engineering and the treatment of ischemic diseases.
机译:本发明涉及通过使用特异性转录因子将间充质干细胞转化为内皮细胞的方法。更具体地,本发明涉及通过使用特异性转录因子例如Oct4,Nanog,Tal1和LMO2将间充质干细胞转化为内皮细胞的方法。根据本发明,在细胞的重编程因子中,与癌症的诱导不直接相关的两种基因和在间充质干细胞中不表达或在转录中低水平表达的另外两种转录因子。选择和组合与血管发育有关的因子,从而开发出用于将间充质干细胞例如成年细胞或成年干细胞转化为内皮细胞的方法,因此,该方法具有用于生产内皮细胞的作用。在组织工程和缺血性疾病的治疗中构成再生组织。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号